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Microglial motilityPatients with Parkinson's disease show persistent microglial activation in the areas of the brain where the
degeneration of dopaminergic neurons takes place. The reason for maintaining this activated state is still
unknown, but it is thought that this persistent microglial activation may contribute to the degeneration of
dopaminergic neurons. In this study, we report the microanatomical details of microglia and the relationship
between microglia and neurons in the substantia nigra pars compacta of Parkinsonian monkeys years after
insult with MPTP. We observed that microglial cells appear polarized toward dopaminergic neurons in
MPTP-treated macaques compared to untreated animals and present clear phagocytic characteristics, such as
engulﬁng gliaptic contacts, an increase in Golgi apparatus protein machinery and ball-and-chain phagocytic
buds. These results demonstrate that activated microglia maintain phagocytic characteristics years after
neurotoxin insult, and phagocytosis may be a key contributor to the neurodegenerative process.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Microglial activation is associated with the release of cytokines, an
increase in particular membrane receptors, changes in morphology,
and the self-induction of directional motility and polarity (Kreutzberg,
1996; Nimmerjahn et al., 2005; Barcia et al., 2011). The purpose of
microglial activation in neurodegenerative diseases remains unclear.
In Parkinson's disease (PD) patients, the areas of the brain that contain
dopaminergic degeneration show high levels of activatedmicroglia that
are maintained for decades (McGeer et al., 1988). The same effect is ob-
served in humans intoxicatedwithMPTP (Langston et al., 1999) aswell
as in long-term MPTP-induced Parkinsonian macaques (McGeer et al.,
2003; Barcia et al., 2004). However, the speciﬁc role of microglia during
this persistent stage is still under scrutiny. We and others have recently
reported that in an experimental mouse model of PD in which
Parkinsonism was induced by MPTP, microglial motility leads to the, 1-methyl-4-phenyl-1,2,3,6
cta; TH, tyrosine hydroxylase;
130, cis-Golgi matrix protein
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dx.doi.org/10.1016/j.jneuroimformation of complex body-to-body contacts between microglia and
dopaminergic neurons that result in the phagocytosis of neuronal cell
bodies in the areas of degeneration (Barcia et al., 2012; Depboylu
et al., 2012). In mice, interactions between microglia and neurons are
transient and precede the elimination of damaged dopaminergic neurons
(Barcia et al., 2012).
To study the phagocytic characteristics of microglia in long-term
Parkinsonism, we analyzed different parameters of microglial activa-
tion in the substantia nigra pars compacta (SNpc) in a group of
macaques suffering from MPTP-induced Parkinsonism. We observed
clear phagocytic features of microglia years after MPTP treatment,
such as an increased number of contacts between microglia and
dopaminergic neurons and the increase of phagocytic domains, as
indicated by the increase of the Golgi apparatus protein machinery
and ball-and-chain phagocytic buds. These characteristics are persistent
years after MPTP treatment, which suggests that phagocytosis is an
important aspect of microglial activation in chronic Parkinsonism that
contributes to neurodegeneration.
2. Material and methods
2.1. Parkinsonian monkeys
In this study, we used a brain bank to obtain brain tissue samples
from chronic Parkinsonian macaques (Macaca fascicularis). We studiedristics of microglia in the substantia nigra of long-term Parkinsonian
.2013.05.001
2 C. Barcia et al. / Journal of Neuroimmunology xxx (2013) xxx–xxxthese macaques throughout the years in our primate unit. All of the
studies that were performed in primates before 2006 were carried out
in accordance with the protocols from the states members of the
European Union (2003/65/CE) and the National Institutes of Health
Guide for the Care and Use of Laboratory Animals (NIH Guide, revised
1996). The experiments that were performed in monkeys after 2006
met the recommendations of the Weatherall report, the Guidelines
promulgated by the European Convention for the protection of
Vertebrate Animals used for Experimental and other scientiﬁc purposes
of the Council of Europe (no. 123, June 15th, 2006), the European
Communities Council Directive 2010/63/ECC, and the University of
Murcia Approved protocols.
We analyzed samples obtained from young adult macaques from
both sexes. Samples from eight animals were used in the present
work. Four animals were treated with MPTP and four animals were
untreated controls (Table 1). The monkeys were treated weekly with
low doses of intravenous MPTP (0.3 mg/kg) according to previous
protocols (Herrero et al., 1993; Barcia et al., 2003). Each animal received
a different number of doses according to the level of Parkinsonism and
their susceptibility to MPTP. None of the animals received L-DOPA
or other dopaminergic agonists. Several researchers deﬁned the degree
of Parkinsonism in the animals after each dose as well as the progression
of the Parkinsonian syndrome. Motor symptoms were assessed using a
previously described rating scale ranging from 0 to 25 (Herrero et al.,
1993). The degree of disability in the monkeys increased with every
new injection and remained stable for months or years. Susceptible
MPTP-treated monkeys showed Parkinsonian symptoms and displayed
different degrees of bradykinesia and akinesia, and sporadic freezing
phenomena. Some of the monkeys presented action tremor, paradoxical
kinesia and occasionally vertical and horizontal saccadic ocular move-
ments. Susceptible monkeys also displayed a typical Parkinsonian
posture. The animals were euthanized one to 5 years after the last
MPTP administration.
2.2. Tissue staining
The monkeys were euthanized by injection with pentobarbital after
ketamine anesthesia one, two or ﬁve years after the last dose of MPTP.
The brain was quickly removed, dissected and ﬁxed for 3 days in 4%
paraformaldehyde that was dissolved in 0.1 M phosphate buffer. The
ﬁxed mesencephalon was sectioned into 40 μm thick serial sections
(Microm, HM400). Series of sections that were regularly spaced at
intervals of 1440 μm were stained for tyrosine hydroxylase (TH)
(sheep polyclonal antibody 1:500; Chemicon, Temecula, CA, USA) to
identify dopaminergic neurons, Iba-1 (rabbit polyclonal antibody
1:500; Wako, Chuo-Ku, Osaka, Japan) to identify microglial cells, and
cis-Golgi Matrix protein 130 (GM130) (1:500; Abcam, Cambridge, UK)
to detect the Golgi apparatus. Sections from all of the animals were
stained simultaneously and under the same experimental conditions.
2.2.1. Immunohistochemistry and immunoﬂuorescence
2.2.1.1. DAB detection. Sections of the SNpc (40 μm) were used to
detect speciﬁc cells and structures via immunohistochemistry.Table 1
Motor score and MPTP accumulative dose of used monkeys.
Monkey Sex Motor score MPTP accumulative dose mg/kg
C1 Male 0.0 0
C2 Male 0.0 0
C3 Female 0.0 0
C4 Male 0.0 0
P1 Male 3.5 1.8
P2 Female 4.2 0.9
P3 Male 5.0 1.8
P4 Female 9.2 0.9
Please cite this article as: Barcia, C., et al., Persistent phagocytic characte
macaques, J. Neuroimmunol. (2013), http://dx.doi.org/10.1016/j.jneuroimEndogenous peroxidase activity was inhibited with 0.3% H2O2, and
non-speciﬁc Fc binding sites were blocked with 10% horse serum.
The sections were incubated for 48 h (room temperature, constant
shaking) with the primary antibody (see above) diluted in PBS
containing 1% horse serum, 0.5% Triton X-100, and 0.1% sodium
azide. The sections were incubated for 4 h in the secondary antibody
that was diluted in antibody solution. Binding of the antibody was
detected with the avidin–biotin peroxidase ABC kit (Vectastain, Vector
Labs). Sections were mounted on gelatin-coated slides and dehydrated
in graded ethanol series and xylene before the addition of a coverslip.
2.2.1.2. Immunoﬂuorescence. For immunoﬂuorescence, 40 μm sections
were treated with 0.5% citrate buffer (65 °C, with constant shaking)
for 30 min to maximize antibody penetration into the tissue. Non-
speciﬁc Fc binding sites were blocked with 10% horse serum, and the
sections were incubated for 48 h (room temperature, constant shak-
ing) with primary antibody diluted in PBS containing 1% horse serum,
0.5% Triton X-100, and 0.1% sodium azide. The sections were incubated
for 4 h with the labeled secondary antibody and were then washed
with PBS and incubated with the DAPI solution (1:1000) in 1× PBS
for 30 min. The sections were washed, mounted, and examined using
ﬂuorescence (Zeiss Axioplan 2) or using confocal microscopy (Leica
DMIRE2). The secondary antibodies used are as follows: Alexa 488-
conjugated, Alexa 594-conjugated or Alexa 647-conjugated (1:1000)
(Molecular Probes). For F-actin staining, sections were incubated with
Alexa Fluor 488-phalloidin or 647-phalloidin (1:500 in PBS; Molecular
Probes) for 2 h at room temperature after immunostaining. After
washing, the sections were incubated with a DAPI solution for 30 min.
The sectionswerewashed again,mounted and examined by ﬂuorescence
(Zeiss, Axioplan 2) or confocal microscopy (DMIRE2, Leica Microsystems,
Exton, PA).
2.2.1.3. Quantiﬁcation and sterological analysis. The nigrostriatal path-
way was deﬁned according to the Monkey Brain Atlas (Paxinos
et al., 1999). Quantiﬁcation of DAB or ﬂuorescently labeled cells in the
SNpcwas performed on coronal sections fromeach animal. The number
of cells was estimated with an optical fractionator probe using a
computer assisted image analysis systemwith a Zeiss Axioplan 2micro-
scope connected to a digital camera. The region of interest was traced
using the 1.25× objective. The number of cells was measured in
200 × 200 μm dissectors covering the surface of the analyzed region.
Labeled cells were counted using the 40× objective, and frames were
counted throughout the delineated area of the SNpc in each section
via the optical fractionator. Two representative sections of the SNpc
were used for staining in monkey brains. Representative sections from
the monkeys were chosen according to the criteria previously deﬁned
by Olzewski and Baxter (1954). The sections contained the ventral
area of the SNpc (in primates corresponding to the α + β area at
the level of the III cranial nerve output), which is known to show the
highest degree of dopaminergic loss and glial activation in humans
(Damier et al., 1999) and non-human primates (Herrero et al., 1993).
The data are expressed as the absolute number of positive cells in each an-
atomical region analyzed. The results are expressed as the mean ± SEM.
3. Confocal analysis and 3D rendering
The brain sections were examined using a Leica DMIRE2 confocal
microscope with a 63× oil objective and Leica Confocal Software
(Leica Microsystems). A series of optical sections were analyzed to
determine an upper and lower threshold using the Z/Y position for
the Spatial Image Series setting. The optical series covered a 20 μm
thick slice of tissue with 0.5 μm per optical section. The confocal
microscope settings were established and maintained by Leica and
local technicians for optimal resolution. (For further details, see previous
publications (Barcia et al., 2011). Contacts were deﬁned as areas where
co-localization of both markers (Iba-1 and TH) occurred between tworistics of microglia in the substantia nigra of long-term Parkinsonian
.2013.05.001
3C. Barcia et al. / Journal of Neuroimmunology xxx (2013) xxx–xxxcells in at least two 0.5-μm-thick optical sections. A thin area of co-
localization can be observed between the two ﬂuorophores. The ﬁnal
confocal images are illustrated as they appear throughout the stack
of sections as a simple 0.5-μm-thick layer or as a transparency of all of
the layers merged together.
Three-dimensional reconstructions of the stacks of confocal
images were rendered in the Imaris software (Bitplane Scientiﬁc
Software. Zurich. Switzerland). Different surface effects were applied
in the 3D rendering to show the structures in the real planes. Videos
of the rotations were also generated with Imaris and were edited
with iMovie Software (Apple Inc. Cupertino, CA) to obtain the ﬁnal
versions.3.1. Quantiﬁcation of activated microglia phenotypes
Sections of the SNpc from monkeys underwent immunoﬂuores-
cence to visualize microglial cells (Iba-1+ cells). The sections were
scanned with a confocal microscope as described above, and the termi-
nal microglial tips per microglial cell were quantiﬁed along the z-axis.
The microglial area and terminal tips were quantiﬁed using confocal
images of the Iba-1+ cells. The scanned confocal planeswith a thickness
of 0.5 μm that contain Iba-1+ cells were processed with the image soft-
ware Image-J in order to obtain a black and white image. The area of 50
microglial cells (speciﬁed by Iba-1 staining) in the SNpc of each animal
was measured in the processed images. Similarly, sections were co-
stained for Iba-1 and GM130, and the area occupied by GM130 was
quantiﬁed in Iba-1+ cells using the same method described for Iba-1.
Two different researchers did all of the quantiﬁcations blindly.3.2. Quantiﬁcation of intercellular contacts
Intercellular contacts between microglial cells and dopaminergic
neurons or ﬁbers were quantiﬁed using stereological methods in
the confocal stacks of images of the SNpc. The number of contacts
per ﬁeld between cells that are positive for Iba-1 and TH was quanti-
ﬁed in 0.5 μm single layers from the 20-μm-thick confocal stacks of
images. The contacts between microglial cells and dopaminergic
neurons were identiﬁed by the convergence of red and green ﬂuores-
cence, which formed a thin yellow area. The contacts were classiﬁed
into four categories: Pr-Pr, contact between a microglial process
and a dopaminergic process; B-Pr, contact between a microglial cell
body and a dopaminergic process; Pr-B, contact between a microglial
process and a dopaminergic neuron cell body; and B-B, contact
between a microglial cell body and a dopaminergic neuron cell body.
The number of contacts per DA ﬁber (Pr-Pr and B-Pr) was quantiﬁed
using the total number of remaining ﬁbers, which was quantiﬁed
using unbiased stereological methods (Gundersen, 1986). The number
of B-B and Pr-B contacts per neuron was quantiﬁed for each neuron
along the z plane. The length of the contacts between processes and
neurons was quantiﬁed using Leica Confocal software. All parameters
(number of contacts, number of dopaminergic ﬁbers and neurons,
number of contacts per neuron and the length of the contact) were
quantiﬁed in 5 dissectors (sample ﬁelds) per single layer of the 20-
μm-thick stacks. For each analysis, 8 stacks per brain region per animal
were analyzed. The ﬁnal result for the length of the contact was the
average of at least 150 events per animal.4. Statistical analysis
The data are expressed as the mean ± SEM. A statistical analysis
was performed using a student's t-test or one-way ANOVA test
followed by a post hoc analysis (Tukey's test). The null hypothesis
was rejected for an α risk equal to 5%.Please cite this article as: Barcia, C., et al., Persistent phagocytic characte
macaques, J. Neuroimmunol. (2013), http://dx.doi.org/10.1016/j.jneuroim5. Results
5.1. There is an increase in microglial polarity in chronic
Parkinsonian macaques
To understand whether microglial polarization and the formation of
engulﬁng gliapses takes place in chronic Parkinsonian primates, we
analyzed the brain sections of macaques with stable Parkinsonism by
applying techniques and imaging protocols that were previously used
in mice (Barcia et al., 2012). The primates were analyzed years after
MPTP treatment. The results indicate that macaques with Parkinsonism
show loss of dopaminergic neurons in the SNpc and a persistent
increase in microglial activation (Fig. 1A–C), which has been the focus
of recent extended studies in our group (Barcia et al., 2011). Although
the number of Iba-1+ microglial cells did not change in the SNpc of
Parkinsonian monkeys compared to control animals, the microglia
clearly showed an activated phenotype, which was characterized by
an increased cell body size and an increased number of terminal tips
(Fig. 1D–E).
Because this increase in terminal tips may reﬂect the polarization of
microglial cells toward damaged neurons, we analyzed the anatomical
relationship between microglia and neurons in the SNpc of chronic
Parkinsonian monkeys. Strikingly, years after the induction of Parkin-
sonism, microglial cells remain in a polarized state toward neighboring
dopaminergic neurons when compared to those of control animals.
A detailed confocal analysis indicated that there were an increased
number of contacts betweenmicroglia and the remainingdopaminergic
neurons in the SNpc years after the last MPTP insult. The analysis of the
entire SNpc showed a prominent increase of interactions between
microglial ﬁlopodia and dopaminergic structures (Fig. 2A and B).
However, the contacts betweenmicroglial cell bodies anddopaminergic
neurons are similar to those of the controls. Importantly, an analysis
of particular sub-regions of the SNpc revealed that in Parkinsonian
macaques, the number of body-to-body gliapse-like contacts remained
higher than controls only in the ventral area of the SNpc, which is an
area that is known to undergo the highest loss of dopaminergic neurons
in Parkinsonian primates (Fig. 2C–E). In addition, the area of contact
between microglia and dopaminergic neurons, including the neurites
and neuronal bodies, was also increased in Parkinsonian monkeys
(Fig. 2F).
5.2. Microglia show persistent phagocytic characteristics
A confocal analysis of the micro-anatomical characteristics of
microglial cells in the SNpc of Parkinsonian macaques revealed
that microglia exhibit phagocytic characteristics in the areas of
neurodegeneration. One of the key elements, observed previously
in the mouse MPTP-induced model, is an increase of Golgi appara-
tus protein machinery in microglial cells. This increase indicates
that the microglia in the degenerating areas contain phagocytic
and secretory functionalities. In macaques, we found that there is
an increase in Golgi apparatus protein machinery, as indicated by
GM130 staining, in Parkinsonian macaques compared to control
animals (Fig. 3A–C). This increase observed in the SNpc suggests that
microglial cells remain in a persistent phagocytic state in chronic
Parkinsonism. Further micro-anatomical analyses indicate that micro-
glial cells contain numerous phagocytic buds in the SNpc of Parkinso-
nian monkeys (Fig. 3D–F and Supplementary Movies 1 and 2). These
structures are rounded enlargements located at themicroglial branches
and display a ball-and-chain-like structure (Fig. 3D). These structures
are reminiscent of the phagocytic events responsible for the elimination
of apoptotic newborn cells in the adult mouse hippocampus (Sierra
et al., 2010). In addition, a zoom-in confocal analysis indicated
that phagocytic buds speciﬁcally contain GM130-expressing cisternae
(Fig. 3E). Finally, three-dimensional reconstructions revealed the exis-
tence of engulﬁng gliapses in the SNpc of Parkinsonian monkeysristics of microglia in the substantia nigra of long-term Parkinsonian
.2013.05.001
Fig. 1.Microglial cells undergo morphological changes in Parkinsonian monkeys. (A) Chronic MPTP-treated macaques present with a high depletion of dopaminergic neurons in the
SNpc. Pictures of TH immunostaining are depicted. The illustration shows the anatomical area of the SNpc. RN; red nucleus, SNpc; substantia nigra pars compacta, CP; Cerebral
Pedunculus, III; third cranial nerve output. Scale bar: 2 mm. (B) A stereological quantiﬁcation of TH+ neurons indicated a dramatic decrease in dopaminergic neurons in chronic
Parkinsonian monkeys compared to control animals. No changes were observed in the number of Iba-1+ microglial cells. (C) Microglial cells undergo drastic morphological changes
in the SNpc in MPTP-treated monkeys. Confocal images of the SNpc immunostained for TH and Iba-1 reveal that microglial cells increase in size and contain a greater number of
terminal tips that contact the dopaminergic neurons in chronic Parkinsonian monkeys. Scale bar: 50 μm. (D) Microglial cells show an increased shape and size for years after
MPTP treatment. Confocal images from the SNpc were analyzed in detail, and representative images of the cells are shown. Scale bar: 40 μm. (E) The numbers of terminal tips
of microglial cells are signiﬁcantly increased in MPTP treated monkeys. *p b 0.05 (student's t-test).
4 C. Barcia et al. / Journal of Neuroimmunology xxx (2013) xxx–xxx(Fig. 4). These structures were characterized by the engulfment of
a pycnotic nucleus by a microglial cell, suggesting an ongoing degener-
ative process (Fig. 4). Three-dimensional reconstructions revealed that
the microglial Golgi apparatus also surrounds the engulfed nucleus,
suggesting an active secretory and phagocytic domain.
6. Discussion
In this study, we show that microglial cells maintain phagocytic
characteristics in the areas of the brain where the degeneration ofPlease cite this article as: Barcia, C., et al., Persistent phagocytic characte
macaques, J. Neuroimmunol. (2013), http://dx.doi.org/10.1016/j.jneuroimdopaminergic neurons takes place in chronic Parkinsonian monkeys
years after MPTP insult. These microglial cells also possess an ongoing
polarization of motility towards the degenerating neurons. These
results indicate that microglia phagocytize dying dopaminergic cell
bodies years after treatment with a neurotoxin, which is consistent
with the well-established idea that there is a long term activation of
microglial cells in Parkinsonian patients.
Contacts made between microglial and neuronal cell bodies,
which are deﬁned as gliapses, are signiﬁcantly increased only in
the ventral SNpc, which is the area with the highest vulnerability toristics of microglia in the substantia nigra of long-term Parkinsonian
.2013.05.001
Fig. 2.Microglial cells establish gliapses with dopaminergic neurons in the SNpc of chronic Parkinsonian macaques. (A) Microglial cell processes and cell bodies establish contacts
with dopaminergic neurites and cell bodies in monkeys. (1) Confocal image showing a microglial process (green) in contact with a dopaminergic neurite (red). (2) Microglial
processes contacting a dopaminergic neuron cell body. (3) A microglial cell body in contact with a dopaminergic neurite. (4) A microglial cell body in contact with the cell body
of a dopaminergic neuron. The cell nuclei were counterstained with DAPI (blue). Scale bar in 3: 30 μm. (B) Increase of contacts between microglia and dopaminergic neurons in
MPTP monkeys. The types of contact between microglial cells and dopaminergic neurons were classiﬁed into four categories: Pr-Pr, contact between a microglial process and
dopaminergic process; B-Pr, contact between a microglial cell body and dopaminergic process; Pr-B, contact between a cell body of a dopaminergic neuron and processes of microglial
cells; and B-B, contact between a microglial cell body and a dopaminergic neuron cell body. A stereological quantiﬁcation of the detailed confocal examination demonstrates that the
number of microglial cell processes in contact with dopaminergic processes [Pr-Pr] and with dopaminergic cell bodies [Pr-B] increases signiﬁcantly in chronic Parkinsonian macaques.
The contacts between microglial cell bodies and dopaminergic structures (B-Pr and B-B) were unchanged. (TOTAL/Pr = [Pr-Pr] + [B-Pr]), TOTAL/Ne = [Pr-B] + [B-B]. *p b 0.05.
(C) Gliapse-type contact between a microglial cell and a dopaminergic neuron in the ventral SNpc of a Parkinsonian monkey. Lateral z-axis views are also shown. The yellow arrows
indicate the contact. (D) Detail of the gliaptic contact. (E) Quantiﬁcation of the number of body-to-body contacts in the sub-regions of the SNpc. A signiﬁcant increase in body-to-body
contacts was observed only in the ventral area of the SNpc, which is an area where dopaminergic degeneration is high *p b 0.05, **p b 0.02. (F) The quantiﬁcation of the contact surface
between microglial processes and dopaminergic neurons, either neurites or dopaminergic cell bodies, increases in chronic Parkinsonian macaques. *p b 0.05; **p b 0.01.
5C. Barcia et al. / Journal of Neuroimmunology xxx (2013) xxx–xxxMPTP. It is thought that the vulnerability of dopaminergic neurons of
this area is due to many factors such as the levels of neuromelanin
and calbindin (Yamada et al., 1990; Gibb and Lees, 1991). Thus, the
present results indicate that there is an association between neuro-
nal damage and gliapse formation, which suggest that microglial
phagocytosis is an important event in Parkinsonian degeneration
especially in vulnerable regions.Please cite this article as: Barcia, C., et al., Persistent phagocytic characte
macaques, J. Neuroimmunol. (2013), http://dx.doi.org/10.1016/j.jneuroimThese microglial characteristics are speciﬁc to primates because
the results found in macaques are in contrast with previous results
obtained in mice (Barcia et al., 2012). In monkeys, the physical con-
tact between microglial cells and neurons persists throughout the
course of the disease, while in mice, cell-to-cell contact between mi-
croglia and neurons is transient and precedes neuronal elimination
(Barcia et al., 2012). In the mouse model of PD, the engulﬁng processristics of microglia in the substantia nigra of long-term Parkinsonian
.2013.05.001
Fig. 3.Microglial cells present phagocytic features in the SNpc of chronic Parkinsonian macaques. (A) Microglial cells in the SNpc of chronic Parkinsonian monkeys show increased
expression of GM130 compared to control animals. Scale bar: 50 μm. (B) Detailed confocal analysis in the SNpc indicated that microglial GM130 shows peri-nuclear staining with
some cisterns in the microglial processes of control monkeys. However, microglial cells from Parkinsonian macaques present a hypertrophic Golgi in the SNpc. Scale bar: 20 μm.
(C) Quantiﬁcation of the area occupied by GM130 expression. (D) Top panel: three-dimensional transparency of a dopaminergic neuron (red) surrounded by microglial cells
(green) in the ventral area of the SNpc of a chronic Parkinsonian monkey. Microglial cells show numerous phagocytic ball-and-chain buds in the areas of dopaminergic degener-
ation (white arrows). Bottom panel: detail of a ball-and-chain phagocytic bud in a microglial cell from the SNpc of a Parkinsonian monkey. Scale bar: 25 μm. (E) Confocal images of
the SNpc of a Parkinsonian macaque show that microglial cells form numerous buds (yellow arrows) that are in close proximity to the remaining dopaminergic neurons. Images 1, 2
and 3 show higher magniﬁcation from the white insert depicted in the merged image Iba-1/GM130/TH. Iba-1 ball-and-chain buds (1) contain Golgi cisterns (2), which co-localize in
the same structure (3). Scale bar: 25 μm. (F) The quantiﬁcation of the number of phagocytic buds revealed an increase in microglial cells in the SNpc of Parkinsonian macaques.
6 C. Barcia et al. / Journal of Neuroimmunology xxx (2013) xxx–xxxand the formation of gliapses lasts until the occurrence of cell death in
dopaminergic neurons, at which point cellular contacts and polariza-
tions return to their normal state. In the present study, we show that
the phagocytic features of microglial cells are persistent in primates,
suggesting that there is ongoing neuronal damage. The reasons for
the differences between the two species remain unclear. Different
protocols to administer MPTP to non-human primates have been
used, and all have resulted in similar levels of microglial activation
(Vazquez-Claverie et al., 2009). In contrast, mice downregulate
the inﬂammatory response once the degenerative process resolves
(Czlonkowska et al., 1996). These results suggest that dopaminergic
neurons in primates are more sensitive than dopaminergic neuronsPlease cite this article as: Barcia, C., et al., Persistent phagocytic characte
macaques, J. Neuroimmunol. (2013), http://dx.doi.org/10.1016/j.jneuroimin rodents. The neurons remaining in the SNpc in primates are likely
to be in a damaged state and may release signals that induce phago-
cytosis mediated by the surrounding microglial cells. Furthermore,
the persistent production of cytokines, such as IFN-γ and TNF-α, in
primates may also induce microglial activation (Barcia et al., 2011).
Taken together, our results suggest that persistent microglial
activation in PD patients may lead to phagocytosis in the areas of the
brain where neurodegeneration occurs. This increase in phagocytic
activity may exacerbate the degenerative process. Therefore, monitor-
ing microglial activation during the progression of PD and treating
patients with anti-inﬂammatory drugs may prevent neuronal loss that
is mediated by phagocytosis.ristics of microglia in the substantia nigra of long-term Parkinsonian
.2013.05.001
Fig. 4. Engulﬁng events in the SNpc of Parkinsonian macaques. (A) Phagocytic gliapse in chronic Parkinsonian monkeys. (1) Confocal three-dimensional transparency of a stack of
images of a phagocytic gliapse in the ventral SNpc of a Parkinsonian monkey. Iba-1 (green) and GM130 (magenta) are shown together with DAPI counterstaining (cyan). (2) Central
0.5-μm-thick optical section of the stacked images at the level of the pycnotic engulfed nucleus. Scale bar: 15 μm. (B) Three-dimensional rendering of the engulﬁng gliapse from 1A.
(1) A microglial cell is engulﬁng an extra-nucleus. (2) The pycnotic extra-nucleus is surrounded by several Golgi cisterns. (3) Isolated detail of the phagocytic event with higher
magniﬁcation.
7C. Barcia et al. / Journal of Neuroimmunology xxx (2013) xxx–xxxSupplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.jneuroim.2013.05.001.
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